| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4003980 | American Journal of Ophthalmology | 2010 | 12 Pages |
Abstract
Given sufficient time, mycophenolate mofetil was effective in managing ocular inflammation in approximately half of the treated patients. Treatment-limiting side effects were observed in 12% of patients and typically were reversible.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Ebenezer Daniel, Jennifer E. Thorne, Craig W. Newcomb, Siddharth S. Pujari, R. Oktay Kaçmaz, Grace A. Levy-Clarke, Robert B. Nussenblatt, James T. Rosenbaum, Eric B. Suhler, C. Stephen Foster, Douglas A. Jabs, John H. Kempen,